Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1227.37 | 245 / 245 | 100% | 14.29 | 502 / 502 |
thymus | 100% | 1981.57 | 653 / 653 | 99% | 12.46 | 600 / 605 |
intestine | 100% | 1312.46 | 966 / 966 | 98% | 15.24 | 517 / 527 |
kidney | 100% | 867.38 | 89 / 89 | 98% | 9.90 | 881 / 901 |
stomach | 100% | 771.97 | 359 / 359 | 97% | 13.62 | 278 / 286 |
brain | 100% | 1198.37 | 2641 / 2642 | 96% | 9.34 | 677 / 705 |
adrenal gland | 100% | 1254.20 | 257 / 258 | 96% | 7.94 | 221 / 230 |
breast | 100% | 972.87 | 459 / 459 | 94% | 10.85 | 1056 / 1118 |
lung | 100% | 962.62 | 576 / 578 | 95% | 9.52 | 1093 / 1155 |
bladder | 100% | 1010.24 | 21 / 21 | 91% | 9.76 | 459 / 504 |
uterus | 100% | 1223.01 | 170 / 170 | 91% | 8.26 | 416 / 459 |
esophagus | 100% | 877.91 | 1442 / 1445 | 89% | 5.56 | 162 / 183 |
ovary | 99% | 945.99 | 179 / 180 | 77% | 4.86 | 332 / 430 |
skin | 100% | 809.73 | 1804 / 1809 | 74% | 4.35 | 350 / 472 |
pancreas | 73% | 221.49 | 239 / 328 | 97% | 9.22 | 173 / 178 |
spleen | 100% | 474.79 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 790.58 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 554.02 | 1310 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.79 | 44 / 45 |
heart | 95% | 427.97 | 818 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.96 | 26 / 29 |
muscle | 84% | 271.17 | 678 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 65% | 1070.51 | 602 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 2.38 | 45 / 80 |
liver | 8% | 18.31 | 18 / 226 | 24% | 2.06 | 98 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902275 | Biological process | regulation of chromatin organization |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0060218 | Biological process | hematopoietic stem cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_2000096 | Biological process | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
GO_2000035 | Biological process | regulation of stem cell division |
GO_0007379 | Biological process | segment specification |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0010467 | Biological process | gene expression |
GO_0008023 | Cellular component | transcription elongation factor complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0140030 | Molecular function | modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MLLT3 |
Protein name | Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3) MLLT3 super elongation complex subunit Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 isoform 1 Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 isoform 3 MLLT3 super elongation complex subunit (Myeloid/lymphoid or mixed-lineage leukemia (Trithorax homolog, Drosophila) translocated to, 3, isoform CRA_a) |
Synonyms | AF9 hCG_1811108 YEATS3 |
Description | FUNCTION: Chromatin reader component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA . Specifically recognizes and binds acylated histone H3, with a preference for histone H3 that is crotonylated . Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors . Recognizes and binds histone H3 crotonylated at 'Lys-9' (H3K9cr), and with slightly lower affinity histone H3 crotonylated at 'Lys-18' (H3K18cr) . Also recognizes and binds histone H3 acetylated and butyrylated at 'Lys-9' (H3K9ac and H3K9bu, respectively), but with lower affinity than crotonylated histone H3 . In the SEC complex, MLLT3 is required to recruit the complex to crotonylated histones . Recruitment of the SEC complex to crotonylated histones promotes recruitment of DOT1L on active chromatin to deposit histone H3 'Lys-79' methylation (H3K79me) . Plays a key role in hematopoietic stem cell (HSC) maintenance by preserving, rather than conferring, HSC stemness . Acts by binding to the transcription start site of active genes in HSCs and sustaining level of H3K79me2, probably by recruiting DOT1L . . |
Accessions | ENST00000380338.9 [P42568-1] A0A0D9SF09 A0A6Q8PGU4 P42568 B1APT5 ENST00000469261.5 A0A0S2Z449 A0A0S2Z448 ENST00000630269.2 [P42568-2] A0A6Q8PH64 ENST00000491137.5 ENST00000380321.5 ENST00000629733.3 |